Condition

Psychotic Disorder NOS

ClinicalTrials.gov condition label

Clinical trials4

Recruiting0

Common interventions7

Lead sponsors shown4

Clinical trials

4 shown

Prednisolone Addition for Patients With Recent-onset Psychotic DisorderNCT02949232 · 2014-07-01

The Effect of N-Acetyl Cysteine on Cortical Erosion in Early Stage SchizophreniaNCT01339858 · 2011-05-01

An Integrated Program for the Treatment of First Episode of PsychosisNCT01321177 · 2010-07-01

Integrated Care in Psychotic Disorders With Severe Mental IllnessNCT01888627 · 2007-05-01

Common interventions

Community CareBEHAVIORAL1 Integrated careOTHER1 Integrated TreatmentBEHAVIORAL1 N-Acetyl CysteineDRUG1 Placebo Oral TabletDRUG1 PrednisoloneDRUG1 sugar pillOTHER1

Leading sponsors

Indiana University1 Northwell Health1 UMC Utrecht1 Universitätsklinikum Hamburg-Eppendorf1

Trial status mix

COMPLETED2

TERMINATED1

UNKNOWN1

Phase mix

NA2

PHASE42

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.